Mereo BioPharma Group

1D

1W

1M

3M

YTD

1Y

5Y

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.

About MREO

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).

CEO

Denise Vera Scots-Knight

CEODenise Vera Scots-Knight

Employees

36

Employees36

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

2015

Founded2015

Employees

36

Employees36

MREO Key Statistics

Market cap

84.22M

Market cap84.22M

Price-Earnings ratio

-2.00

Price-Earnings ratio-2.00

Dividend yield

—

Dividend yield—

Average volume

23.71M

Average volume23.71M

High today

$0.551

High today$0.551

Low today

$0.5204

Low today$0.5204

Open price

$0.546

Open price$0.546

Volume

5.91M

Volume5.91M

52 Week high

$3.26

52 Week high$3.26

52 Week low

$0.20

52 Week low$0.20

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell

0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.